InnoCare Pharma : INSIDE INFORMATION PROPOSED ISSUE OF RMB SHARES AND LISTING ON THE SCI-TECH BOARD OF THE SHANGHAI STOCK EXCHANGE

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

InnoCare Pharma Limited ፕ༐਄ശᔼᖹϞࠢʮ̡

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 9969)

INSIDE INFORMATION

PROPOSED ISSUE OF RMB SHARES AND LISTING ON THE SCI-TECH

BOARD OF THE SHANGHAI STOCK EXCHANGE

This announcement is made by InnoCare Pharma Limited (the "Company", together with its subsidiaries, the "Group") pursuant to Rule 13.09(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and the Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

On 11 March 2021, the board of directors of the Company resolved that, the Company proposes to issue RMB shares on the Science and Technology Innovation Board of the Shanghai Stock Exchange (the "Sci-Tech Board") (the "Proposed Issue of RMB Shares").

As the Proposed Issue of RMB Shares is subject to the obtaining of the necessary regulatory approvals and may or may not proceed, shareholders and potential investors should exercise caution when dealing in the securities of the Company. The Company will make further announcement(s) to disclose any developments in respect of the Proposed Issue of RMB Shares in accordance with the Listing Rules and other applicable laws and regulations as and when appropriate. This announcement is for information purposes only and is not intended to, and does not, constitute, or form part of, an invitation or offer to acquire, purchase or subscribe for any securities of the Company.

By order of the Board

InnoCare Pharma Limited

Dr. Jisong Cui

Chairperson and executive Director

Hong Kong, 11 March 2021

As at the date of this announcement, the Board of Directors of the Company comprises Dr. Jisong Cui as Chairperson and executive Director, Dr. Renbin Zhao as executive Director, Dr. Yigong Shi, Mr. Quanhong Yuan, Mr. Shan Fu and Mr. Lijun Lin as non-executive Directors, and Dr. Zemin Zhang, Ms. Lan Hu and Dr. Kaixian Chen as independent non-executive Directors.